Veeva Systems (VEEV) Stock Forecast & Price Target

$211.32

+1.19 (+0.57%)

(As of 10/11/2024 08:51 PM ET)

Veeva Systems - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 24 Analyst Ratings

Sell
1

Hold
7

Buy
16

Based on 24 Wall Street analysts who have issued ratings for Veeva Systems in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 24 analysts, 1 has given a sell rating, 7 have given a hold rating, and 16 have given a buy rating for VEEV.

Consensus Price Target

$232.96
10.24% Upside

According to the 24 analysts' twelve-month price targets for Veeva Systems, the average price target is $232.96. The highest price target for VEEV is $286.00, while the lowest price target for VEEV is $173.00. The average price target represents a forecasted upside of 10.24% from the current price of $211.32.

VEEV Analyst Ratings Over Time

Type	Current Forecast 10/15/23 to 10/14/24	1 Month Ago 9/15/23 to 9/14/24	3 Months Ago 7/17/23 to 7/16/24	1 Year Ago 10/15/22 to 10/15/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	16 Buy rating(s)	15 Buy rating(s)	14 Buy rating(s)	15 Buy rating(s)
Hold	7 Hold rating(s)	7 Hold rating(s)	6 Hold rating(s)	9 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$232.96	$229.96	$228.05	$219.58
Forecasted Upside	10.24% Upside	5.51% Upside	21.88% Upside	1.61% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Unless you plan on working until the day you die...read this (Ad)

Traditional financial wisdom might lead you to think the ONLY way to reach your retirement goals is to “buy and hold” assets and hope they grow enough for you to be able to retire.… The goal being that the assets spin off enough income to cover your expenses. Unfortunately, that just doesn’t cut it anymore. And most folks need a better plan. Because here are the facts…

Click here to join my free training

VEEV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

VEEV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Veeva Systems Stock vs. The Competition

Type	Veeva Systems	Medical Companies	S&P 500
Consensus Rating Score	2.63	2.79	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	10.24% Upside	10,372.69% Upside	6.88% Upside
News Sentiment Rating	Positive News See Recent VEEV News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/8/2024	BNP Paribas 3 of 5 stars	A. Degasperi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$286.00	+41.70%
10/1/2024	Guggenheim 3 of 5 stars		Boost Target	Buy ➝ Buy	$233.00 ➝ $249.00	+20.00%
9/9/2024	JPMorgan Chase & Co. 3 of 5 stars		Boost Target	Neutral ➝ Neutral	$203.00 ➝ $208.00	-6.04%
9/3/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$197.00 ➝ $207.00	-4.36%
8/29/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$180.00 ➝ $192.00	-11.20%
8/29/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$250.00 ➝ $250.00	+17.15%
Unless you plan on working until the day you die...read this (Ad) Traditional financial wisdom might lead you to think the ONLY way to reach your retirement goals is to “buy and hold” assets and hope they grow enough for you to be able to retire.… The goal being that the assets spin off enough income to cover your expenses. Unfortunately, that just doesn’t cut it anymore. And most folks need a better plan. Because here are the facts… Click here to join my free training
8/29/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$220.00 ➝ $240.00	+14.67%
8/29/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$230.00 ➝ $235.00	+12.28%
8/29/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$225.00 ➝ $230.00	+15.37%
8/29/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$260.00 ➝ $260.00	+30.42%
8/29/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$245.00 ➝ $251.00	+25.91%
8/29/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$204.00 ➝ $240.00	+20.39%
8/27/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$256.00 ➝ $273.00	+37.72%
8/26/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$185.00 ➝ $215.00	+7.47%
7/9/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Larsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$240.00	+31.21%
5/31/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$220.00 ➝ $210.00	+20.90%
5/31/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$250.00 ➝ $210.00	+20.71%
5/31/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Materne Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	In-Line ➝ In-Line	$230.00 ➝ $200.00	+13.97%
5/31/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Underweight ➝ Underweight	$210.00 ➝ $173.00	-10.91%
3/5/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$232.00 ➝ $250.00	+10.67%
3/4/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$225.00 ➝ $270.00	+21.62%
3/1/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$219.00 ➝ $248.00	+10.30%
2/22/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$225.00	+2.46%
10/25/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Equal Weight ➝ Overweight	$211.00 ➝ $229.00	+16.20%
3/2/2023	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Outperform	$215.00 ➝ $230.00	+38.45%
12/6/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform	$184.00	+10.02%
12/2/2022	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$242.00 ➝ $233.00	+21.72%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 07:28 AM ET.

Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, October 11, 2024. Please send any questions or comments about these Veeva Systems pros and cons to contact@marketbeat.com.

Veeva Systems
Bull Case

Here are some ways that investors could benefit from investing in Veeva Systems Inc.:

Veeva Systems Inc. has a strong track record of beating earnings estimates, indicating consistent financial performance and potential for growth.
Analysts have given Veeva Systems Inc. a "Moderate Buy" consensus rating with an average price target of $232.96, suggesting positive sentiment and potential upside.
Veeva Systems Inc. has a market capitalization of $34.03 billion, reflecting the company's size and stability in the market.
The company's stock price has shown resilience, with a 52-week high of $236.90, indicating investor confidence and potential for further growth.
Veeva Systems Inc. provides cloud-based software for the life sciences industry, a sector with high demand and growth potential, offering a niche market advantage.

Veeva Systems
Bear Case

Investors should be bearish about investing in Veeva Systems Inc. for these reasons:

Despite positive analyst ratings, there is a risk associated with the stock as one research analyst has rated it as a sell, indicating potential concerns about future performance.
Veeva Systems Inc. has a price-to-earnings ratio of 61.05 and a PEG ratio of 1.99, which may suggest the stock is currently overvalued compared to its earnings growth potential.
10.50% of the stock is owned by company insiders, which could lead to conflicts of interest or lack of alignment with external shareholders.
The company's beta of 0.81 indicates lower volatility compared to the market, potentially limiting short-term trading opportunities for investors seeking higher returns.
While Veeva Systems Inc. has shown strong financial performance, there may be competitive pressures in the cloud-based software industry that could impact future growth and profitability.

VEEV Forecast - Frequently Asked Questions

: According to the research reports of 24 Wall Street equities research analysts, the average twelve-month stock price forecast for Veeva Systems is $232.96, with a high forecast of $286.00 and a low forecast of $173.00.
: 24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veeva Systems in the last twelve months. There is currently 1 sell rating, 7 hold ratings and 16 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" VEEV shares.
: According to analysts, Veeva Systems's stock has a predicted upside of 10.24% based on their 12-month stock forecasts.
: Veeva Systems has been rated by research analysts at Bank of America, Barclays, BNP Paribas, Citigroup, Guggenheim, JPMorgan Chase & Co., Needham & Company LLC, Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, TD Cowen, Truist Financial, and UBS Group in the past 90 days.
: Analysts like Veeva Systems less than other "medical" companies. The consensus rating score for Veeva Systems is 2.63 while the average consensus rating score for "medical" companies is 2.79. Learn more on how VEEV compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Protect Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

This page (NYSE:VEEV) was last updated on 10/14/2024 by MarketBeat.com Staff

From Our Partners